The US Food and Drug Administration (FDA) approved an oral contraceptive — the first of its kind — that is intended both to prevent pregnancy and reduce the risk for neural tube defects in newborns if and when users of the pill give birth. The new contraceptive contains levomefolate calcium, a metabolite of folic […]